ALB and breast adenocarcinoma: CME is also the main uptake pathway for electropositive human serum albumin (HSA)-based NPs loaded with lapatinib in SK-BR-3 human breast adenocarcinoma cells, having an approximated size of 140 nm [31] and in modified albumin NPs as galactosylated curcumin-loaded BSA NPs (Gal-BSA-Cur) in human colon adenocarcinoma Caco-2 cells [29].